글로벌 톨테로딘 시장 - 산업 동향 및 2028년까지의 예측

시장 분석 및 통찰력: 글로벌 톨테로딘 시장

글로벌 톨테로딘 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 위에 언급된 연구 예측 기간 동안 3.60%의 건강한 CAGR로 성장하고 있다고 분석합니다.

톨테로딘은 항콜린제 계열의 약물에 속합니다. 톨테로딘은 과민성 방광(근육의 통제되지 않는 수축으로 인해 요실금이 발생 함)을 치료하는 데 사용됩니다. 따라서 배뇨 과정을 제어하기 어려워집니다. 무스카린 길항제는 무스카린 수용체에 대한 아세틸콜린의 효과를 억제합니다. 중추 신경계에서. 항콜린제는 신경절 후 무스카린 수용체를 경쟁적으로 억제하는 항콜린제 계열입니다. 이들은 부교감 신경계에 관여합니다. 약물의 지방친화성의 특정 특성에 따라 어떤 장기계가 영향을 받을지 결정할 수 있습니다. 지방친화성 계열의 약물에 속하는 아트로핀이나 벤즈트로핀은 혈액-뇌 장벽을 통과하여 중추 신경계(CNS)에 영향을 미칩니다. 이프라트로피움과 부틸스코폴라민은 지방친화성이 낮아 천식, 위장관계( 과민성 대장 증후군 ), 비뇨 생식기 치료 를 위해 호흡기계에 투여합니다. 그러나 건조증과 복용량 증가와 같은 다양한 부작용으로 인해 항콜린성 증후군이 발생할 수 있으며, 이는 고열, 빈맥, 혼수 상태로 이어집니다. 국립 당뇨병 및 소화기 및 신장 질환 연구소에서 수집한 데이터에 따르면 만성 신장 질환 의 전체 유병률은 약 14%입니다. 의사와 비뇨기과 의사가 일반적으로 처방하는 약물은 Pfizer의 Detrol(톨테로딘 타르트레이트), Astellas의 Vesicare입니다.

The increased prevalence of neurological disorders, rise in geriatric population, increased demand for self-medication, rise in patent expiration rates and increased consciousness about the symptoms and prevention of urinary incontinence and rise in drug approvals are the factors expected to drive the market growth. However, the rigid regulatory policies, increased cost, poor reimbursement framework, side effects associated with the consumption of the drugs are the restraints which are likely to hinder the market growth. The opportunities which are predicted to propel the market are improvement in healthcare scenario, rising initiatives by market players, expansion in drug portfolio and successful clinical trials In June 2011, Pfizer, had conducted its first online clinical trials, which was reviewed by FDA,  on the  investigational new drug application (IND) for the patients to participate and gather awareness about the safety and efficacy of Detrol LA (tolterodine tartrate), for curing overactive bladder (OAB).The lack of expertise in developing the correct formulation and dosage of drugs, stiff completion among market players, rise in alternatives are the challenges.

This Tolterodine market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Tolterodine Market Scope and Market Size

• The tolterodine market is segmented on the basis of type, oral type, applications, mode of purchase and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
• On the basis of type, the tolterodine market is segmented into natural, synthetic and semi-synthetic.
• On the basis of oral type, the tolterodine market is segmented into capsule, tablets.
• On the basis of application, the tolterodine market is segmented into urinary incontinence, respiratory, gastrointestinal.
• On the basis of mode of purchase, the tolterodine market is segmented into Prescription and Over the Counter.
• On the basis of distribution channel, the tolterodine market has also been segmented into hospital pharmacies, retail pharmacies, online pharmacies, clinics.

Tolterodine Market Country Level Analysis

Tolterodine market is analysed and market size information is provided by country, type, oral type, applications, mode of purchase and distribution channel as referenced above.

The countries covered in the tolterodine market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America is expected to hold the largest market share due to the increased prevalence of chronic renal disorders, increased funding by government and Research and Development, rise in disposable income. The percent of adults diagnosed with kidney disease are 2.4% Asia-Pacific is expected to account for the fastest growing market due to large patient population, minimum duration of patent approvals for development and approval of new drugs. Middle East and Africa are anticipated to deliver lucrative opportunities in the market due to geriatric population.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Tolterodine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Tolterodine Market Share Analysis

Tolterodine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Tolterodine market.

톨테로딘 시장에서 다루는 주요 업체는 Pfizer Inc, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Sandoz International GmbH, Macleods Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd, Hetero, NANJING ZENKOM PHARMACEUTICAL CO, LTD., Actavis, Allergan, astellas, Janssen Pharmaceuticals, Inc. 등 국내 및 글로벌 업체입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60405